First Presentation of diabetes as diabetic ketoacidosis in a case of Friedreich’s ataxia

Clinical Diabetes

Volumn 33, Issue 2, 2015, Pages 84-86

  Chakraborty, Partha Pratim ^a   Ray, Sayantan ^a   Bhattacharjee, Rana ^a   Ghosh, Sujoy ^a   Mukhopadhyay, Pradip ^a   Mukhopadhyay, Satinath ^a   Chowdhury, Subhankar ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BICARBONATE; C PEPTIDE; GLUCOSE; INSULIN; KETONE; POTASSIUM;

ADOLESCENT; ARTERIAL GAS; ARTICLE; ATAXIC GAIT; BLOOD PRESSURE; BREATHING RATE; CARDIOMYOPATHY; CASE REPORT; DIABETIC KETOACIDOSIS; DYSMETRIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FRDA GENE; FRIEDREICH ATAXIA; GENE; GENETIC ANALYSIS; HEART RATE; HUMAN; KNEE DISEASE; MALE; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; SENSORIMOTOR NEUROPATHY;

EID: 84927925739     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.33.2.84     Document Type: Article

References (14)

1. Melo M, Fagulha A, Barros L, Guimaraes J, Carrilho F, Carvalheiro M. Friedreich ataxia and diabetes mellitus-family study. Acta Med Port 2005;18:479-483
2. Hewer RL, Robinson N. Diabetes mellitus in Friedreich’s ataxia. J Neurol Neurosurg Psychiatry 1968;31:226-231
3. Chamberlain S, Shaw J, Rowland A, et al. Mapping of mutation causing Friedreich’s ataxia to human chromosome 9. Nature 1988;334:248-250
4. Campuzano V, Montermini L, Molto MD, et al. Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996;271:1423-1427
5. Delatycki MB, Paris DB, Gardner RJ, et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet 1999;87:168-174
6. Filla A, De Michele G, Cavalcanti F, et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 1996;59:554-560
7. Bird TD, Turner JL, Sumi SM, Bierman EL. Abnormal function of endocrine pancreas and anterior pituitary in Friedreich’s ataxia: studies in a family. Ann Intern Med 1978;88;478-481
8. Gucev Z, Tasic V, Jancevska A, et al. Friedreich ataxia (FA) associated with diabetes mellitus type 1 and hyperthrophic cardiomyopathy. Bosn J Basic Med Sci 2009;9:107-110
9. Schoenle EJ, Boltshauser EJ, Baekkeskov S, Landin Olsson M, Torresani T, von Felten A. Preclinical and manifest diabetes mellitus in young patients with Friedreich’s ataxia: no evidence of immune process behind the islet cell destruction. Diabetologia 1989;32:378-381
10. Khan RJ, Andermann E, Fantus IG. Glucose intolerance in Friedreich’s ataxia: association with insulin resistance and decreased insulin binding. Metabolism 1986;35:1017-1023
11. Coppola G, Marmolino D, Lu D, et al. Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich’s ataxia. Hum Mol Genet 2009;18:2452-2461
12. Cnop M, Igoillo-Esteve M, Rai M, et al. Central role and mechanisms of β-cell dysfunction and death in Friedreich ataxia associated diabetes. Ann Neurol 2012;72:971-982
13. Koeppen AH. Friedreich’s ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci 2011;303:1-12
14. Holst JJ, Burcelin R, Nathanson E. Neuroprotective properties of GLP-1: theoretical and practical applications. Curr Med Res Opin 2011;27:547-558